✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Strides Pharma Science Ltd.

STAR

Market Cap
₹7,873 Cr.
P/E
2.19

Strides Pharma Science Ltd.

  • Strides Pharma Scien
  • FDC
  • Procter&Gamble Healt
  • TJI Pharma - Small Cap
FAQs on Strides Pharma Science Ltd. Shareprice

Strides Pharma Scien has given lower returns compared to its competitors.
Strides Pharma Scien has grown at ~-3.01% over the last 10yrs while peers have grown at a median rate of 15.62%

Strides Pharma Scien is not expensive.
Latest PE of Strides Pharma Scien is 2.22, while 3 year average PE is 30.35.
Also latest EV/EBITDA of Strides Pharma Scien is 10.94 while 3yr average is 22.2.

View FAQ's On Business
Growth Table
  • Strides Pharma Science Ltd.
  • FDC
  • Procter&Gamble Healt
Balance Sheet
  • Strides Pharma Science Ltd.
  • FDC
  • Procter&Gamble Healt
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Strides Pharma Science Ltd.
  • FDC
  • Procter&Gamble Healt
Cash Flow
  • Strides Pharma Science Ltd.
  • FDC
  • Procter&Gamble Healt
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Strides Pharma Science Ltd.
  • FDC
  • Procter&Gamble Healt
Quarterly Results
  • Strides Pharma Science Ltd.
  • FDC
  • Procter&Gamble Healt
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Strides Pharma Science Ltd. Financials

Balance sheet of Strides Pharma Scien is strong.
But short term working capital might become an issue for this company.

The net debt of Strides Pharma Scien is decreasing.
Latest net debt of Strides Pharma Scien is ₹1,659 Crs as of Mar-25.
This is less than Mar-24 when it was ₹2,060 Crs.

Yes, profit is increasing.
The profit of Strides Pharma Scien is ₹358 Crs for TTM, -₹70.61 Crs for Mar 2024 and -₹202.63 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Strides Pharma Scien latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech